RDHLRedHill Biopharma Ltd.

RDHL Stock Price, Valuation & Chart | RedHill Biopharma Ltd.

$0.740-0.13 (-14.83%)

At close · 02 Sept 2026, 08:00 pm

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic RDHL intrinsic value RDHL calculated fair value vs price

Overview Financials Dividends Ratios

RDHL Historical price chart

RDHL Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization2.33M

PE Ratio0.15

EPS5.0

Trading Volume1.39M

Today's High/Low0.88/0.72

Dividend Yield0.00

52 Week High/Low2.79/0.57

Shares Outstanding3.14M

RDHL Financial Statement

RDHL Analyst ratings

RDHL Analysis & performance metrics

RDHL Company profile

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs,…

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in…

RDHL Management team

Name

Position

Gilead Raday MPhil, MScCOO

Chief Operating Officer

Guy Goldberg J.D.

Chief Business Officer

Dror Ben-AsherCEO

Co-Founder, Chairman & Chief Executive Officer

Adi Frish

Chief Corporate & Business Development Officer

Patricia Anderson B.Sc. RAC

Senior Vice President of Regulatory Affairs

Razi IngberCFO

Chief Financial Officer

Rick D. ScruggsCTO

Chief Commercial Officer & Director

Reza Fathi Ph.D.

Senior Vice President of Research & Development

Name

Position

Gilead Raday MPhil, MScCOO

Chief Operating Officer

Guy Goldberg J.D.

Chief Business Officer

Dror Ben-AsherCEO

Co-Founder, Chairman & Chief Executive Officer

Adi Frish

Chief Corporate & Business Development Officer

Patricia Anderson B.Sc. RAC

Senior Vice President of Regulatory Affairs

Razi IngberCFO

Chief Financial Officer

Rick D. ScruggsCTO

Chief Commercial Officer & Director

Reza Fathi Ph.D.

Senior Vice President of Research & Development

Management Team

Gilead Raday MPhil, MScCOO

Chief Operating Officer

Guy Goldberg J.D.

Chief Business Officer

Dror Ben-AsherCEO

Co-Founder, Chairman & Chief Executive Officer

Adi Frish

Chief Corporate & Business Development Officer

Patricia Anderson B.Sc. RAC

Senior Vice President of Regulatory Affairs

Razi IngberCFO

Chief Financial Officer

Rick D. ScruggsCTO

Chief Commercial Officer & Director

Reza Fathi Ph.D.

Senior Vice President of Research & Development

Management

Gilead Raday MPhil, MScCOO

Chief Operating Officer

Guy Goldberg J.D.

Chief Business Officer

Dror Ben-AsherCEO

Co-Founder, Chairman & Chief Executive Officer

Adi Frish

Chief Corporate & Business Development Officer

Patricia Anderson B.Sc. RAC

Senior Vice President of Regulatory Affairs

Razi IngberCFO

Chief Financial Officer

Rick D. ScruggsCTO

Chief Commercial Officer & Director

Reza Fathi Ph.D.

Senior Vice President of Research & Development

Total 8 executives

RDHL Frequently asked questions

What is RedHill Biopharma Ltd. (RDHL) Stock Price?

Current stock price of RedHill Biopharma Ltd. (RDHL) stock is $0.740. The stock price is -14.83% lower in the session. The intraday range can be seen from this page. Volume of RedHill Biopharma Ltd. (RDHL) stock is 1.39M.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the RedHill Biopharma Ltd. (RDHL) stock price going up or down today?

The stock price of RedHill Biopharma Ltd. (RDHL) can change with earnings, company news, and overall market sentiment. RedHill Biopharma Ltd. operates in the Healthcare / Drug Manufacturers - Specialty & Generic market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the RedHill Biopharma Ltd. stock expensive at its current price?

Whether RedHill Biopharma Ltd. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for RDHL on this page is 0.15. EPS on this page is 5.00. Compare those figures with peers and growth expectations before deciding if the current RedHill Biopharma Ltd. price is justified.

How has the stock price of RedHill Biopharma Ltd. (RDHL) performed historically?

Historical performance for RedHill Biopharma Ltd. (RDHL) is shown on the price chart on this page. Review multi-period moves alongside volume to see how RDHL reacted to past earnings and market events.

Should I buy RedHill Biopharma Ltd. (RDHL) stock, at this price?

Buying RedHill Biopharma Ltd. (RDHL) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.